Macrogenics (MGNX) Tops Q3 EPS by 38c

Macrogenics (NASDAQ: MGNX) reported Q3 EPS of $0.28, $0.38 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $10.39 million versus the consensus estimate of $49.24 million.

For earnings history and earnings-related data on Macrogenics (MGNX) click here.

You May Also Be Interested In

• Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
• Barclays Downgrades Equity LifeStyle Properties (ELS) to Equalweight
• Light & Wonder to report Q2 results Aug. 4, reaffirms FY26 outlook